Shibata S
Shibata Laboratory of Natural Medicinal Materials, C/o Minophagen Pharmaceutical Co., Ltd., Tokyo, Japan.
Yakugaku Zasshi. 2000 Oct;120(10):849-62. doi: 10.1248/yakushi1947.120.10_849.
Licorice, the root of Glycyrrhiza spp. (Fabaceae), has been used since ancient Egyptian, Greek, and Roman times in the West and since the Former Han era (the 2nd-3rd century B.C.) in ancient China in the East. In traditional Chinese medicine, licorice is one of the most frequently used drugs. In Japan, the oldest specimen of licorice introduced from China in the middle of the 8th century still exists in Shosoin, the Imperial Storehouse, in Nara. Extracts of licorice were recommended as a remedy for gastric ulcer by Revers of the Netherlands in 1946, which was soon withdrawn owing to its side effects. Carbenoxolon sodium, glycyrrhetinic acid (GA) hemisuccinate Na, was prepared from licorice to treat peptic ulcer in the UK. In Japan for the past 60 years, a glycyrrhizin (GL) preparation under the name of Stronger Neo-Minophagen C (SNMC) has been used clinically as an antiallergic and antihepatitis agent. GL and GA sometimes induce edema, hypertension, and hypokalemia in patients treated with higher doses and long-term administration. The mechanism of this side effect, pseudoaldosteronism, has been explained as due to the 11-hydroxy-steroid dehydrogenase inhibitory activity of GL and GA. The excess of endogenous cortisol produced combines with the renal mineral corticoid receptor, which promotes an aldosterone-like action. GL and GA reduce alanine transaminase (ALT) and aspartate transaminase (AST) values in the serum. This hepatoprotective effect has recently been explained as the inhibitory effects of GL and GA on immune-mediated cytotoxicity against hepatocytes and on nuclear factor (NF)-kappa B, which activates genes encoding inflammatory cytokines in the liver. To exclude the side effects and enhance the therapeutic activities, chemical modification of GL and GA has been performed. Deoxoglycyrrhetol (DG), homo- and heteroannular diene homologs of dihemiphthalates, showed a remarkable improvement in antiinflammatory, antiallergic, and antiulcer activities in animal experiments. Immunomodulating effects of GL, GA, and DG derivatives, which induce interferon-gamma and some other cytokines, have been demonstrated in relation with their antiviral activities. Antiinflammatory, antitumorigenic, and antimalarial effects of licorice flavonoids have also been investigated.
甘草是豆科甘草属植物的根,在西方自古埃及、希腊和罗马时代起就已被使用,在东方自中国古代西汉时期(公元前2至3世纪)起就已被使用。在传统中医中,甘草是最常用的药物之一。在日本,8世纪中叶从中国引进的最古老的甘草标本仍保存在奈良的皇家宝库正仓院。1946年,荷兰的雷弗斯推荐甘草提取物作为治疗胃溃疡的药物,但由于其副作用很快就被撤回。在英国,从甘草中制备了甘珀酸钠(甘草次酸半琥珀酸酯钠)用于治疗消化性溃疡。在过去60年里,日本有一种名为强力新诺明C(SNMC)的甘草酸制剂临床上一直用作抗过敏和抗肝炎药物。甘草酸和甘草次酸在高剂量和长期给药的患者中有时会引起水肿、高血压和低钾血症。这种副作用,即假性醛固酮增多症,其机制被解释为甘草酸和甘草次酸具有11-羟基类固醇脱氢酶抑制活性。产生的内源性皮质醇过量与肾脏盐皮质激素受体结合,从而促进类似醛固酮的作用。甘草酸和甘草次酸可降低血清中的丙氨酸转氨酶(ALT)和天冬氨酸转氨酶(AST)值。最近,这种肝脏保护作用被解释为甘草酸和甘草次酸对免疫介导的肝细胞细胞毒性以及对激活肝脏中编码炎性细胞因子的基因的核因子(NF)-κB具有抑制作用。为了排除副作用并增强治疗活性,人们对甘草酸和甘草次酸进行了化学修饰。去氧甘草次醇(DG),即二半邻苯二甲酸酯的同环和异环二烯同系物,在动物实验中显示出抗炎、抗过敏和抗溃疡活性有显著改善。甘草酸、甘草次酸和DG衍生物的免疫调节作用,可诱导γ-干扰素和其他一些细胞因子,已被证明与其抗病毒活性有关。甘草黄酮的抗炎、抗肿瘤和抗疟疾作用也已得到研究。